COVID-19 pandemic
Health Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death.
Sources: CBC News
Changes
- Health Canada approves the use of the Pfizer's anti-COVID-19 viral drug Paxlovid for people aged above 18 years who are at risk of severe disease and death.
- Health Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death.